Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of rituximab is effective in
treating pulmonary alveolar proteinosis by leading to an improvement in lung function and
disease status.